6d
Zacks Investment Research on MSNGlaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue?It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...
The history of the pharmaceutical industry in the town goes back to the post-war era, when Glaxo built a production site on a former iron works. At the time, pharmaceutical production sites were ...
4mon
Zacks.com on MSNGSK (GSK) Q3 Earnings Surpass EstimatesOver the last four quarters, the company has surpassed consensus EPS estimates three times. Glaxo, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $10.42 ...
BRENTFORD, Britain (AP) — BRENTFORD, Britain (AP) — GSK plc (GSK) on Wednesday reported fourth-quarter earnings of $530.5 million. On a per-share basis, the Brentford, Britain-based company ...
What is the share price of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) today on NSE? As on Mar 12, 2025, Glaxosmithkline Pharmaceuticals Ltd (GLAXO)’s share price on NSE is Rs 2683.1 What is the ...
I've already discussed Astra's results this week. Here's why Glaxo looks by far the better bet. If you didn't bother delving into the results, you might wonder what the grounds for optimism are.
A Chinese court on Friday fined British drug-maker GlaxoSmithKline 3.0 billion Yuan (490 million dollars) following a nearly year-long bribery probe, the company said. The fine, levied by the ...
Will the recent positive trend continue leading up to its next earnings release, or is Glaxo due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results